nimustine has been researched along with Myelodysplastic Syndromes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, M; Matsumoto, T; Nin-Asai, R; Saito, S; Sawada, M; Yokota, K | 1 |
| Ikeya, T; Nitta, Y; Sakakibara, A; Tomita, Y | 1 |
| Hamada, J; Hamaguchi, Y; Hayashi, Y; Nakada, M; Shimizu, Y; Sugimori, N; Watanabe, T | 1 |
| Kageshita, T; Kuribayashi, N; Ono, T | 1 |
4 other study(ies) available for nimustine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Humans; Male; Melanoma; Myelodysplastic Syndromes; Nimustine; Skin Neoplasms | 2014 |
Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Female; Foot Diseases; Humans; Melanoma; Middle Aged; Myelodysplastic Syndromes; Nimustine; Retrospective Studies; Vincristine | 2011 |
Neuro-Sweet disease mimicking recurrent anaplastic astrocytoma associated with therapy-related myelodysplastic syndrome: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Astrocytoma; Brain; Brain Neoplasms; Carcinoma; Chemoradiotherapy; Drug Eruptions; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Nimustine; Sweet Syndrome | 2012 |
Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dacarbazine; Humans; Leukocyte Count; Male; Melanoma; Middle Aged; Myelodysplastic Syndromes; Nimustine; Skin Neoplasms; Vincristine | 2000 |